Form 4: HRT Financial LP Acquires Shuttle Pharmaceuticals Stock

HRT Financial LP reports a significant acquisition of common stock in Shuttle Pharmaceuticals Holdings, Inc., increasing its beneficial ownership.

Summary

• HRT Financial LP, a 10% owner of Shuttle Pharmaceuticals Holdings, Inc., has acquired 3,959 shares of common stock.
• The transaction occurred on July 1, 2026, with shares purchased at a price of $3.30 per share.
• Following this transaction, HRT Financial LP beneficially owns 82,556 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as a significant owner is increasing their stake, but it does not provide new strategic or financial performance information.

Positives

• HRT Financial LP, a significant shareholder, has increased its stake in Shuttle Pharmaceuticals, indicating confidence in the company.
• The acquisition of 3,959 shares at $3.30 per share suggests a belief in the current valuation or future prospects of the company.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are crucial for tracking insider and significant shareholder activity, providing insights into their confidence levels in a company's stock.

Stakeholder Impact

• Shareholders may view the increased stake by a 10% owner as a positive signal of confidence in the company's future.

Key Dates

Keywords

Form 4, SEC Filing, Beneficial Ownership, Stock Acquisition, Shuttle Pharmaceuticals Holdings, HRT Financial LP, Common Stock, 10% Owner